INFORMING THE PATIENT ABOUT OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN KAZAKHSTAN
Introduction: The implantable cardioverter defibrillator (ICD) has been implemented in most countries for the treatment of patients at high risk of sudden death from arrhythmia, and has been proven to be effective. To provide high quality care it was identified that system have to patient-oriented. Thus the satisfaction of ICD patients with information about cardioverter-defibrillator implantation one of the crucial issue.
The aim is to study the satisfaction of ICD patients with information about technology cardioverter-defibrillator implantation.
Materials and methods: The online survey was conducted by phone. The oral consent to participate in the survey was obtained. The survey provided in Russian or Kazakh languages, depending patient preferences. The survey was conducted in the period 2020, among patients who received an ICD in the period from 2017 to 2020 in Almaty city and Kyzylorda region. Statistical processing was carried out using the SPSS 13 software. The Local Ethics Committee of Kazakhstan’s Medical University «KSPH» (Almaty, Kazakhstan) approved the study.
Results: The high number of Almaty city respondents in comparison of the Kyzylorda region unsatisfactory with the level of the providing information on the effect of ICD (P <0.009), the impact of ICD on driving a car, traveling, playing sports or other activities, what shock means and when they occur, and how daily life might change (P <0.046). Only respondents from Almaty city assessed neutral or unsatisfactory (P <0.004) on informing how to care for a wound after implantation and to manage pain, symptoms and medication when returning home (P <0.002).
Conclusion: There are needs to improve in providing information on effects of ICD technology in Almaty city higher in comparison with Kyzylorda region.
Количество просмотров: 555
Категория статей:
Оригинальные исследования
Библиографическая ссылка
Begisbayev T.S., Brimzhanova M.D., Akhtaeva N.S., Kosherbayeva L.K., Toleugali Sh.E. Informing the patient about of implantable cardioverter defibrillators in Kazakhstan // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 1, pp. 64-70. doi 10.34689/SH.2022.21.1.008Похожие публикации:
TRENDS IN MORBIDITY AND MORTALITY FROM CHRONIC HEART FAILURE IN ALMATY
СТРУКТУРНО-ФУНКЦИОНАЛЬНЫЕ ИЗМЕНЕНИЯ МИОКАРДА ПОСЛЕ АОРТОКОРОНАРНОГО ШУНТИРОВАНИЯ У ПАЦИЕНТОВ С ИЗБЫТОЧНОЙ МАССОЙ ТЕЛА НА РАЗНЫХ ЭТАПАХ РЕАБИЛИТАЦИИ
МЕДИКО – СОЦИАЛЬНЫЕ, ПСИХОЛОГИЧЕСКИЕ АСПЕКТЫ КАЧЕСТВА ЖИЗНИ БОЛЬНЫХ С ОСТРЫМ ПАНКРЕАТИТОМ
A COMPARATIVE ANALYSIS OF 24-HOUR DIETARY RECALLS AND FOOD FREQUENCY QUESTIONNAIRES ADMINISTERED SIMULTANEOUSLY IN THE KAZAKHSTANI POPULATION
ANALYSIS OF PATIENT SATISFACTION WITH THE QUALITY OF ORGANIZATION OF TREATMENT IN FOREIGN CLINICS